Drug intelligence / Profile preview

ageLOC Meta

Development stage
Unknown
Lead developer
Nu Skin
Modality
Microbiome Therapeutics, Small Molecules
Administration
Oral
01

Overview

ageLOC Meta (marketed as ageLOC Reset in some international regions) is a multi-ingredient dietary supplement developed by Nu Skin Enterprises under the Pharmanex brand. The formulation features a proprietary blend of anthocyanins—specifically cyanidin and delphinidin derived from black currant, bilberry, and black rice—paired with a prebiotic blend of inulin and fructooligosaccharides. The supplement is designed to support 'metabolic flexibility' by modulating the gut microbiome, enhancing intestinal barrier integrity through the support of tight junction proteins, and reducing oxidative stress and systemic inflammation by targeting reactive oxygen species and nuclear factor kappa B pathways. While not an FDA-approved pharmaceutical for specific diseases, it has been clinically studied for its ability to improve core metabolic health markers and promote a healthy microbial environment, particularly in populations dealing with metabolic stress, overweight, or obesity.

Brand names
ageLOC MetaageLOC Reset
Other names
Pharmanex ageLOC MetaPharmanex ageLOC Reset
02

Targets

NF-κBOCLN (Occludin)

Beyond the preview

Go deeper on ageLOC Meta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ageLOC Meta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call